ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - NBTB, FRBA, MPB, TCRR

Stock Information for TCR2 Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TCR2 Therapeutics Inc.

First Bank Announces Third Quarter 2025 Net Income of $11.7 Million
First Bank Announces Third Quarter 2025 Earnings Conference Call
First Bank Announces Second Quarter 2025 Net Income of $10.2 Million
First Bank Announces Second Quarter 2025 Earnings Conference Call
First Bank Announces Completion of $35 Million Subordinated Debt Offering
First Bank Announces First Quarter 2025 Net Income of $9.4 Million
First Bank Announces First Quarter 2025 Earnings Conference Call
First Bank Announces Fourth Quarter 2024 Net Income of $10.5 Million and Full Year Net Income of $42.2 Million

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.